Medical Advisors

Leading experts in Abdominal Wall Reconstruction are actively supporting us in the development and clinical evaluation of our innovative small‑bites suturing device, the Switch®. Top surgeons from the Netherlands, Europe and the United States guide our engineering and clinical teams throughout every stage of product development, ensuring that each iteration aligns with the highest standards of modern surgical practice.

The advisory board’s commitment is grounded in robust clinical evidence: studies have shown that the small‑bites suturing technique significantly reduces postoperative complications such as incisional hernias, leading to improved patient outcomes and lower healthcare costs through fewer reoperations.

A key part of our development strategy is our collaboration with Erasmus Medical Center (Erasmus MC Rotterdam), the renowned academic hospital whose research helped establish small‑bites suturing as the superior standard for abdominal wall closure. Erasmus MC serves as a crucial clinical validation partner, working closely with us to test and validate the Switch® device and its dedicated suture set in real surgical environments.

This partnership strengthens our mission to transform abdominal wall closure by making precision small‑bites suturing faster, more consistent and easier to perform, ultimately enhancing surgical quality and reducing global healthcare expenditures.